Neurology

A new international clinical trial with tofersen confirms that the drug can stop ALS in patients with a SOD1 mutation. With this doctors and researchers show for the first time that, in principle, ALS is a treatable disease. The results have been published in NEJM.

Researchers at UZ Leuven, KU Leuven, VITO and imec have published promising results on the use of a hyperspectral camera to detect protein plaques in the eyes of Alzheimer's patients.

A PET-MR brain scan can detect early changes in people with an increased risk of developing ALS or frontotemporal dementia as a result of a genetic error, as discovered by VIB, KU Leuven and UZ Leuven researchers.